Karo Pharma AB

Karo Pharma AB
Stock Exchange OTC Publication Venue
EPS
SEK4.62
Market Cap
SEK6.25 B
Shares Outstanding
164.33 M
Public Float
48.16 M

Profile

Address
Nybrokajen 7
Stockholm AB 111 48
Sweden
Employees -
Website http://www.karopharma.se
Updated 07/08/2019
Karo Pharma AB is a healthcare company, which engages in the research, development, and distribution of innovative drugs for key medical needs. It focuses on the project portfolio consists of RORgamma, Multiple Sclerosis and Cancer, and T268A Common Cold Spray. The company was founded in 1987 and is headquartered in Stockholm, Sweden.

Financials

View All

Anders O. Lönner
Executive Chairman
Håkan Åström
Independent Director